U.S. Markets open in 57 hrs, 45 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,451.19 | -128.00 | -1.49% |
| NASDAQ | 1,649.51 | 4.39 | 0.27% |
| S&P 500 | 899.22 | -10.70 | -1.18% |
| Day Low 09:30 AM EDT | 15.29 | |
|---|---|---|
| Day High 03:52 PM EDT | 21.675 |
|
| Range | 6.39 | |
| Volume | 49,609 | |
| 30-Day Avg. Vol. | 66,000 |
|
| Difference | -24.83% | |
| Market Cap. | 307.82 M | |
| Change | 66.22 M | |
| Shares Out. | 15.22 M | |
| Percent Traded | 0.33% | |
| Revenue (LFY) | 44.33 M | |
| Earnings (TTM) | -43.06 M | |
| Next Earnings | 11/10/2008 |
|
| EPS (TTM) | -4.05 |
| 52-Wk Low 4/17/08 | 13.14 | |
|---|---|---|
| 52-Wk High 10/16/07 | 31.99 |
|
| Range | 18.85 | |
| Prev. Close 10/9/08 | 15.87 | |
| Today's Open | 15.29 | |
| Change | -3.65% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | — | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -3.00 |
Affymax is designing peptides to give red blood cells a pep talk. The biotechnology firm is researching and developing possible drugs based upon these biological process regulators. Its leading drug candidate ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -1.018 3/31/08 | -1.03 3/31/08 |
-0.012
Missed
|
| Last Quarter | -1.214 6/30/08 | -1.24 6/30/08 |
-0.026
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 19.13 M | 44.34 M |
| Gross Profit | 18.81 M | 43.27 M |
| Operating Income | -19.61 M | -49.14 M |
| Net Income | -18.92 M | -43.07 M |
